197 related articles for article (PubMed ID: 23174862)
1. A small-molecule RGD-integrin antagonist inhibits cell adhesion, cell migration and induces anoikis in glioblastoma cells.
Russo MA; Paolillo M; Sanchez-Hernandez Y; Curti D; Ciusani E; Serra M; Colombo L; Schinelli S
Int J Oncol; 2013 Jan; 42(1):83-92. PubMed ID: 23174862
[TBL] [Abstract][Full Text] [Related]
2. An RGD small-molecule integrin antagonist induces detachment-mediated anoikis in glioma cancer stem cells.
Paolillo M; Galiazzo MC; Daga A; Ciusani E; Serra M; Colombo L; Schinelli S
Int J Oncol; 2018 Dec; 53(6):2683-2694. PubMed ID: 30280197
[TBL] [Abstract][Full Text] [Related]
3. Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair.
Christmann M; Diesler K; Majhen D; Steigerwald C; Berte N; Freund H; Stojanović N; Kaina B; Osmak M; Ambriović-Ristov A; Tomicic MT
Oncotarget; 2017 Apr; 8(17):27754-27771. PubMed ID: 27487141
[TBL] [Abstract][Full Text] [Related]
4. PTTG induces EMT through integrin αVβ3-focal adhesion kinase signaling in lung cancer cells.
Shah PP; Fong MY; Kakar SS
Oncogene; 2012 Jun; 31(26):3124-35. PubMed ID: 22081074
[TBL] [Abstract][Full Text] [Related]
5. A selective cyclic integrin antagonist blocks the integrin receptors alphavbeta3 and alphavbeta5 and inhibits retinal pigment epithelium cell attachment, migration and invasion.
Hoffmann S; He S; Jin M; Ehren M; Wiedemann P; Ryan SJ; Hinton DR
BMC Ophthalmol; 2005 Jun; 5():16. PubMed ID: 15987521
[TBL] [Abstract][Full Text] [Related]
6. Muscone restores anoikis sensitivity in TMZ-resistant glioblastoma cells by suppressing TOP2A via the EGFR/Integrin β1/FAK signaling pathway.
Zou Y; Xu L; Wang W; Zhu X; Lin J; Li H; Chen J; Xu W; Gao H; Wu X; Yin Z; Wang Q
Phytomedicine; 2024 Jul; 129():155714. PubMed ID: 38723526
[TBL] [Abstract][Full Text] [Related]
7. Apigenin Attenuates Melanoma Cell Migration by Inducing Anoikis through Integrin and Focal Adhesion Kinase Inhibition.
Hasnat MA; Pervin M; Lim JH; Lim BO
Molecules; 2015 Nov; 20(12):21157-66. PubMed ID: 26633318
[TBL] [Abstract][Full Text] [Related]
8. Blockade of alpha v beta3 and alpha v beta5 integrins by RGD mimetics induces anoikis and not integrin-mediated death in human endothelial cells.
Maubant S; Saint-Dizier D; Boutillon M; Perron-Sierra F; Casara PJ; Hickman JA; Tucker GC; Van Obberghen-Schilling E
Blood; 2006 Nov; 108(9):3035-44. PubMed ID: 16835373
[TBL] [Abstract][Full Text] [Related]
9. Small-molecule inhibitors of FGFR, integrins and FAK selectively decrease L1CAM-stimulated glioblastoma cell motility and proliferation.
Anderson HJ; Galileo DS
Cell Oncol (Dordr); 2016 Jun; 39(3):229-42. PubMed ID: 26883759
[TBL] [Abstract][Full Text] [Related]
10. Cilengitide targets pediatric glioma and neuroblastoma cells through cell detachment and anoikis induction.
Leblond P; Dewitte A; Le Tinier F; Bal-Mahieu C; Baroncini M; Sarrazin T; Lartigau E; Lansiaux A; Meignan S
Anticancer Drugs; 2013 Sep; 24(8):818-25. PubMed ID: 23728220
[TBL] [Abstract][Full Text] [Related]
11. RGD binding to integrin alphavbeta3 affects cell motility and adhesion in primary human breast cancer cultures.
Georgoulis A; Havaki S; Drosos Y; Goutas N; Vlachodimitropoulos D; Aleporou-Marinou V; Kittas C; Marinos E; Kouloukoussa M
Ultrastruct Pathol; 2012 Dec; 36(6):387-99. PubMed ID: 23181508
[TBL] [Abstract][Full Text] [Related]
12. Astrocytoma adhesion to extracellular matrix: functional significance of integrin and focal adhesion kinase expression.
Rutka JT; Muller M; Hubbard SL; Forsdike J; Dirks PB; Jung S; Tsugu A; Ivanchuk S; Costello P; Mondal S; Ackerley C; Becker LE
J Neuropathol Exp Neurol; 1999 Feb; 58(2):198-209. PubMed ID: 10029102
[TBL] [Abstract][Full Text] [Related]
13. A novel RGD antagonist that targets both alphavbeta3 and alpha5beta1 induces apoptosis of angiogenic endothelial cells on type I collagen.
Meerovitch K; Bergeron F; Leblond L; Grouix B; Poirier C; Bubenik M; Chan L; Gourdeau H; Bowlin T; Attardo G
Vascul Pharmacol; 2003 Feb; 40(2):77-89. PubMed ID: 12646396
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin mediates tumorigenic transformation of a preneoplastic murine cell line by suppressing anoikis: an Arg-Gly-Asp-dependent-focal adhesion kinase-caspase-8 axis.
Hsieh YH; van der Heyde H; Oh ES; Guan JL; Chang PL
Mol Carcinog; 2015 May; 54(5):379-92. PubMed ID: 24249517
[TBL] [Abstract][Full Text] [Related]
15. Alphavbeta3/alphavbeta5 integrins-FAK-RhoB: a novel pathway for hypoxia regulation in glioblastoma.
Skuli N; Monferran S; Delmas C; Favre G; Bonnet J; Toulas C; Cohen-Jonathan Moyal E
Cancer Res; 2009 Apr; 69(8):3308-16. PubMed ID: 19351861
[TBL] [Abstract][Full Text] [Related]
16. Thy-1-mediated cell-cell contact induces astrocyte migration through the engagement of αVβ3 integrin and syndecan-4.
Kong M; Muñoz N; Valdivia A; Alvarez A; Herrera-Molina R; Cárdenas A; Schneider P; Burridge K; Quest AF; Leyton L
Biochim Biophys Acta; 2013 Jun; 1833(6):1409-20. PubMed ID: 23481656
[TBL] [Abstract][Full Text] [Related]
17. Nanofiber-mediated inhibition of focal adhesion kinase sensitizes glioma stemlike cells to epidermal growth factor receptor inhibition.
Srikanth M; Das S; Berns EJ; Kim J; Stupp SI; Kessler JA
Neuro Oncol; 2013 Mar; 15(3):319-29. PubMed ID: 23328812
[TBL] [Abstract][Full Text] [Related]
18. Disintegrin Tablysin-15 Suppresses Cancer Hallmarks in Melanoma Cells by Blocking FAK/Akt/ERK and NF-κB Signaling.
Deng Z; Zeng Q; Chai J; Zhang B; Zheng W; Xu X; Wu J
Curr Cancer Drug Targets; 2020; 20(4):306-315. PubMed ID: 31893992
[TBL] [Abstract][Full Text] [Related]
19. Culture of human breast cancer cell line (MDA-MB-231) on fibronectin-coated surface induces pro-matrix metalloproteinase-9 expression and activity.
Maity G; Choudhury PR; Sen T; Ganguly KK; Sil H; Chatterjee A
Tumour Biol; 2011 Feb; 32(1):129-38. PubMed ID: 20821288
[TBL] [Abstract][Full Text] [Related]
20. The lipoxygenase inhibitor, baicalein, modulates cell adhesion and migration by up-regulation of integrins and vinculin in rat heart endothelial cells.
Hsieh YC; Hsieh SJ; Chang YS; Hsueh CM; Hsu SL
Br J Pharmacol; 2007 Aug; 151(8):1235-45. PubMed ID: 17592510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
